+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Recombinant Human Bone Morphogenetic Protein 2 Market - Global Forecast 2026-2032- Product Image
Recombinant Human Bone Morphogenetic Protein 2 Market - Global Forecast 2026-2032- Product Image
Sale

Recombinant Human Bone Morphogenetic Protein 2 Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6138477
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Recombinant Human Bone Morphogenetic Protein 2 Market is projected to reach USD 593.66 Million in 2026. It is expected to continue growing at a CAGR of 6.42%, reaching USD 858.21 Million by 2032.

Recombinant Human Bone Morphogenetic Protein 2: Executive Overview

Recombinant human bone morphogenetic protein 2 (rhBMP-2) is a bioengineered growth factor used to support bone formation in selected orthopedic, dental, and reconstructive procedures. Its clinical value derives from osteoinductive activity, which can help address situations where autologous bone grafting is limited or less desirable. Adoption depends on evidence of appropriate patient selection, procedural technique, regulatory authorization, reimbursement conditions, and post-market safety monitoring.

Clinical Evidence and Regulatory Scrutiny Are Reshaping Adoption

The landscape is shifting toward more selective use, stronger long-term evidence, and closer evaluation of benefits relative to complications. Clinicians increasingly weigh rhBMP-2 against alternatives such as autograft, allograft, synthetic substitutes, and other biologic approaches. Regulatory labeling, informed consent, dose discipline, handling requirements, and surveillance remain central because outcomes can vary by anatomical site, formulation, delivery method, and patient risk profile.

Artificial Intelligence Is Improving Evidence Generation and Care Pathways

Artificial intelligence can support this field by identifying patterns in clinical records, imaging, and published evidence relevant to fusion, healing, complications, and patient selection. Predictive tools may help clinicians compare treatment pathways, while computer vision can assist with radiographic assessment and longitudinal follow-up. These applications remain dependent on representative data, clinical validation, explainability, cybersecurity, and human oversight; AI does not replace regulatory review or clinical judgment.

Regional Insights: Access and Clinical Practice Differ Across Health Systems

North America combines advanced surgical infrastructure with extensive regulatory and payer scrutiny. Europe emphasizes evidence standards, health-technology assessment, and harmonized but nationally implemented access pathways. Asia-Pacific includes sophisticated markets alongside rapidly expanding healthcare capacity, creating varied adoption conditions. Latin America is shaped by public-private disparities, specialist availability, and procurement constraints. The Middle East is supported by investment in tertiary care but remains heterogeneous across jurisdictions, while Africa faces uneven access to specialized surgery, biologics, diagnostics, and follow-up services.

Group Insights: Economic and Security Blocs Have Distinct Policy Priorities

ASEAN markets reflect diverse regulatory maturity, healthcare financing, and specialist capacity, making local registration and distribution requirements important. BRICS members span large and varied health systems, with priorities that include domestic capability, affordability, and access to advanced care. The European Union places emphasis on common regulatory principles and comparative evidence, while G7 systems generally maintain demanding standards for clinical quality and safety. GCC countries often focus on tertiary-care development and international clinical standards. NATO members do not constitute a single healthcare market, but many share priorities around resilient medical supply chains, preparedness, and interoperability.

Country Insights: Regulatory Pathways and Surgical Capacity Shape Use

Australia and Canada rely on structured regulatory, clinical, and reimbursement processes within publicly oriented systems. Brazil and Mexico combine specialist centers with uneven access and procurement complexity. China and India have broad clinical capacity but substantial regional variation and evolving regulatory environments. Japan, South Korea, Singapore-adjacent ASEAN supply links, and European countries such as France, Germany, Italy, and Spain emphasize evidence, specialist practice, and controlled hospital adoption. The United Kingdom focuses on national guidance, commissioning, and evidence-based use. The United States has substantial procedural expertise but applies close attention to indication, labeling, safety communication, and payer policy. Russia’s access conditions are influenced by regulatory, economic, and supply-chain factors.

Industry Leaders Should Prioritize Evidence, Governance, and Responsible Access

Leaders should align product development and clinical education with clearly defined indications, patient-selection criteria, dose management, and procedure-specific evidence. Post-market surveillance should track both clinical outcomes and adverse events across diverse populations. Partnerships with hospitals and professional societies can strengthen training, while transparent health-economic analyses can support appropriate reimbursement discussions without overstating benefits. Supply-chain resilience, quality controls, data governance, and region-specific regulatory planning should be treated as core strategic capabilities.

Research Methodology: Evidence Triangulation Across Clinical and Policy Sources

This executive summary uses a structured review of the product category, its clinical applications, regulatory considerations, healthcare-system characteristics, and technology trends. Insights are framed qualitatively and avoid market estimates, sizing, shares, and forecasts. Regional, group, and country observations are synthesized from established patterns in healthcare infrastructure, regulatory oversight, reimbursement, specialist capacity, and biologics governance. Conclusions should be validated against current product labeling, peer-reviewed evidence, official guidance, and jurisdiction-specific requirements before operational decisions are made.

Conclusion: Disciplined, Evidence-Based Use Will Define the Category

The strategic role of recombinant human BMP-2 is being defined less by broad availability than by the quality of evidence, appropriateness of use, safety management, and access to capable surgical care. Regional and national differences will continue to influence adoption, while AI may improve patient stratification and evidence workflows when deployed responsibly. Organizations that combine rigorous clinical governance with reliable supply, compliant education, and transparent outcomes measurement will be best positioned to support appropriate use.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Recombinant Human Bone Morphogenetic Protein 2 Market, by Formulation
7.1. Introduction
7.2. Collagen Sponge
7.3. Gel
7.4. Injectable
8. Recombinant Human Bone Morphogenetic Protein 2 Market, by Application
8.1. Introduction
8.2. Dental Augmentation
8.3. Long Bone Repair
8.4. Maxillofacial Surgery
8.5. Spinal Fusion
8.5.1. Interbody Fusion
8.5.2. Posterolateral Fusion
9. Recombinant Human Bone Morphogenetic Protein 2 Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.3.1. Non Teaching Hospitals
9.3.2. Teaching Hospitals
9.4. Specialty Clinics
10. Recombinant Human Bone Morphogenetic Protein 2 Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.5. Retail Pharmacy
11. Recombinant Human Bone Morphogenetic Protein 2 Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Recombinant Human Bone Morphogenetic Protein 2 Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Recombinant Human Bone Morphogenetic Protein 2 Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Baxter International Inc.
15.2. Cellumed Co., Ltd.
15.3. Globus Medical, Inc.
15.4. Johnson & Johnson
15.5. Medtronic plc
15.6. Orthofix Medical Inc.
15.7. RTI Surgical Holdings, Inc.
15.8. Smith & Nephew plc
15.9. Stryker Corporation
15.10. Zimmer Biomet Holdings, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Recombinant Human Bone Morphogenetic Protein 2 Market, Years Considered for the Study
FIGURE 2. Global Recombinant Human Bone Morphogenetic Protein 2 Market, Research Design
FIGURE 3. Global Recombinant Human Bone Morphogenetic Protein 2 Market, Research Framework
FIGURE 4. Global Recombinant Human Bone Morphogenetic Protein 2 Market, Data Triangulation
FIGURE 5. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 7. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Recombinant Human Bone Morphogenetic Protein 2 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Recombinant Human Bone Morphogenetic Protein 2 Market Segmentation & Coverage
TABLE 2. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 3. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 4. Global Collagen Sponge Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Collagen Sponge Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Collagen Sponge Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Gel Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Gel Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Gel Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 14. Global Dental Augmentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Dental Augmentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Dental Augmentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Long Bone Repair Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Long Bone Repair Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Long Bone Repair Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Maxillofacial Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Maxillofacial Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Maxillofacial Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Spinal Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Spinal Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Spinal Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Interbody Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Interbody Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Interbody Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Posterolateral Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Posterolateral Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Posterolateral Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 33. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Non Teaching Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Non Teaching Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Non Teaching Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Teaching Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Teaching Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Teaching Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 49. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 69. North America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 71. North America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 72. North America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 73. North America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. North America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 75. North America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 76. Latin America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Latin America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 78. Latin America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Latin America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 80. Latin America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Latin America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 82. Latin America Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Europe Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Europe Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 85. Europe Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. Europe Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 87. Europe Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Europe Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 89. Europe Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Middle East Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Middle East Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 92. Middle East Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. Middle East Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 94. Middle East Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Middle East Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 96. Middle East Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Africa Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Africa Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 99. Africa Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Africa Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 101. Africa Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Africa Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 103. Africa Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. ASEAN Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 107. ASEAN Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. ASEAN Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 109. ASEAN Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. ASEAN Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 111. ASEAN Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. GCC Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. GCC Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 114. GCC Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. GCC Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 116. GCC Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. GCC Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 118. GCC Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. European Union Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. European Union Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 121. European Union Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. European Union Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 123. European Union Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. European Union Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 125. European Union Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. BRICS Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. BRICS Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 128. BRICS Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. BRICS Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 130. BRICS Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. BRICS Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 132. BRICS Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. G7 Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. G7 Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 135. G7 Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. G7 Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 137. G7 Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. G7 Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 139. G7 Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. NATO Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. NATO Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 142. NATO Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. NATO Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 144. NATO Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. NATO Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 146. NATO Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Global Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. United States Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 149. United States Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 150. United States Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. United States Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 152. United States Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. United States Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 154. United States Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. Canada Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 156. Canada Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 157. Canada Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. Canada Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 159. Canada Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Canada Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 161. Canada Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Mexico Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 163. Mexico Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 164. Mexico Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Mexico Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 166. Mexico Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Mexico Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 168. Mexico Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Brazil Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 170. Brazil Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 171. Brazil Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Brazil Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 173. Brazil Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Brazil Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 175. Brazil Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. United Kingdom Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 177. United Kingdom Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 178. United Kingdom Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. United Kingdom Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 180. United Kingdom Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. United Kingdom Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 182. United Kingdom Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. Germany Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 184. Germany Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 185. Germany Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Germany Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 187. Germany Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Germany Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 189. Germany Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. France Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 191. France Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 192. France Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. France Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 194. France Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. France Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 196. France Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. Russia Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 198. Russia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 199. Russia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Russia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 201. Russia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Russia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 203. Russia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. Italy Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 205. Italy Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 206. Italy Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. Italy Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 208. Italy Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Italy Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. Italy Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. Spain Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 212. Spain Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 213. Spain Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Spain Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 215. Spain Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Spain Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 217. Spain Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. China Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 219. China Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 220. China Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. China Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 222. China Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. China Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. China Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 225. India Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 226. India Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 227. India Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. India Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 229. India Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. India Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. India Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. Japan Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 233. Japan Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 234. Japan Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Japan Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 236. Japan Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Japan Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 238. Japan Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. Australia Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 240. Australia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 241. Australia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Australia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 243. Australia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. Australia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 245. Australia Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. South Korea Recombinant Human Bone Morphogenetic Protein 2 Market Size, 2017-2032 (USD Million)
TABLE 247. South Korea Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 248. South Korea Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. South Korea Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Spinal Fusion, 2017-2032 (USD Million)
TABLE 250. South Korea Recombinant Human Bone Morphogenetic Protein 2 Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. South Korea Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 252. South Korea Recombinant Human Bone Morphogenetic Protein 2 Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Global Recombinant Human Bone Morphogenetic Protein 2 Market Share, by Key Player, 2025
TABLE 254. Global Recombinant Human Bone Morphogenetic Protein 2 Market, Key Experts

Companies Mentioned

  • Baxter International Inc.
  • Cellumed Co., Ltd.
  • Globus Medical, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Orthofix Medical Inc.
  • RTI Surgical Holdings, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.

Related Topics

Related Reports

Bone Morphogenetic Proteins - Global Strategic Business Report - Product Image

Bone Morphogenetic Proteins - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From
Bone Morphogenetic Protein Market - Global Forecast 2026-2032 - Product Image

Bone Morphogenetic Protein Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Human Bone Morphogenetic Protein 9 ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Human Bone Morphogenetic Protein 9 ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Serum Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Serum Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.